Progression of Alzheimer's disease during a three-year follow-up usin. The CERAD-NB total score: Kuopio ALSOVA study

International Psychogeriatrics

Volumn 25, Issue 8, 2013, Pages 1335-1344

  Hallikainen, Ilona ^a   Hänninen, Tuomo ^b   Fraunberg, Mikael ^b   Hongisto, Kristiina ^a   Välimäki, Tarja ^a   Hiltunen, Asta ^c   Karppi, Pertti ^d   Sivenius, Juhani ^a,e   Soininen, Hilkka ^a,b   Koivisto, Anne M ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^d MIKKELI CENTRAL HOSPITAL   (Finland)

^e Brain Research and Rehabilitation Center Neuron   (Finland)

Author keywords

Activities of daily living; Alzheimer's disease; CERAD; Dementia; Neuropsychiatric symptoms; Progression

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE; ALZHEIMER DISEASE COOPERATIVE STUDY ACTIVITIES OF DAILY LIVING INVENTORY; ARTICLE; CLINICAL DEMENTIA RATING; COGNITION; CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMER DISEASE NEUROPSYCHOLOGICAL BATTERY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PSYCHOLOGIC ASSESSMENT;

ACTIVITIES OF DAILY LIVING; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION; DEMENTIA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SOCIOECONOMIC FACTORS;

EID: 84880088075     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610213000653     Document Type: Article

References (30)

1. APA (1994). Diagnostic and Statistical Manual of Mental Disorders 4th edn. Washington DC: American Psychiatric Association.
2. Birks J. (2006). Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews CD005593. Review. PubMed PMID: 16437532
3. Bozoki A. C. An H. Bozoki E. S. and Little R. J. (2009). The existence of cognitive plateaus in Alzheimer's disease. Alzheimer's and Dementia 5 470-478.
4. Chandler M. J. et al. (2005). A total score fo. The CERAD neuropsychological battery. Neurology 65 102-106.
5. Cortes F. et al. (2005). Recent data o. The natural history of Alzheimer's disease: results fro. The REAL.FR study. Journal of Nutrition Health and Aging 9 86-93.
6. Cortes F. et al. (2008). Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients fro. The REAL-FR study. Alzheimer's and Dementia 4 22-29.
7. Cummings J. L. Mega M. Gray K. Rosenberg-Thompson S. Carusi D. A. and Gornbein J. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44 2308-2314.
8. Cummings J. L. Schneider E. Tariot P. N. and Graham S. M. (2006). Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology 67 57-63.
9. Feldman H. H. Van Baelen B. Kavanagh S. M. and Torfs K. E. (2005). Cognition function and caregiving time patterns in patients with mild-to-moderate Alzheimer disease: a 12-month analysis. Alzheimer Disease and Associated Disorders 19 29-36.
10. Folstein M. F. Folstein S. E. andMcHugh P. R. (1975). "Mini-mental state". A practical method for gradin. The cognitive state of patients fo. The clinician. Journal of Psychiatric Research 12 189-198.
11. Galasko D. et al. (1997). An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's disease cooperative study. Alzheimer Disease and Associated Disorders 11(Suppl. 2) S33-S39.
12. Hallikainen I. et al. (2012). Cognitive and neuropsychiatric symptom differences in early stages of Alzheimer's disease: Kuopio ALSOVA study. Dementia and Geriatric Cognitive Disorders Extra 2 209-218. doi:10.1159/ 000338231.
13. Hughes C. P. Berg L. Danziger W. L. Coben L. A. and Martin R. L. (1982). A new clinical scale fo. The staging of dementia. The British Journal of Psychiatry 140 566-572.
14. Karttunen K. et al. (2011). Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease. International Journal of Geriatric Psychiatry 26 473-482. doi:10.1002/gps.2550. Epub 2010 Oct 29.
15. McKhann G. Drachman D. Folstein M. Katzman R. Price D. and Stadlan E. M. (1984). Clinical diagnosis of Alzheimer's disease: report o. The NINCDS-ADRDA Work Group unde. The auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 939-944.
16. McLaughlin T. et al. (2010). Assessment of potential measures in models of progression in Alzheimer disease. Neurology 75 1256-1262.
17. Morris J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43 2412-2414.
18. Morris J. C. et al. (1989). The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39 1159-1165.
19. Morris J. C. et al. (1993). The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change i. The longitudinal assessment of probable Alzheimer's disease. Neurology 43 2457-2465.
20. Pulliainen V. Hokkanen L. Salo J. and Hänninen T. (1999). CERAD-kognitiivinen tehtäväsarja. Käsikirja. [Manual o. The Finnish version o. The CERAD neuropsychological battery]. Kuopio: Suomen Alzheimertutkimusseura ry.
21. Rossetti H. C. Munro Cullum C. Hynan L. S. and Lacritz L. H. (2010). The CERAD Neuropsychologic Battery Total Score an. The progression of Alzheimer disease. Alzheimer Disease and Associated Disorders 24 138-142.
22. Salloway S. et al. (2009). A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 73 2061-2070.
23. Seo E. H. et al. (2010). Total scores o. The CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies. The American Journal of Geriatric Psychiatry 18 801-809.
24. Serra L. et al. (2010). Relationship between cognitive impairment and behavioural disturbances in Alzheimer's disease patients. Behavioural Neurology 23 123-130.
25. Stein J. et al. (2012). The assessment of changes in cognitive functioning: age- education- and gender-specific reliable change indices for older adults tested o. The CERAD-NP battery: results o. The German study on ageing cognition and dementia in primary care patients (AgeCoDe). The American Journal of Geriatric Psychiatry 20 84-97.
26. Steinberg M. et al. (2008). Point and 5-year period prevalence of neuropsychiatric symptoms in dementia. The Cache County Study. International Journal of Geriatric Psychiatry 23 170-177.
27. Stern R. G. et al. (1994). A longitudinal study of Alzheimer's disease: measurement rate and predictors of cognitive deterioration. The American Journal of Psychiatry 151 390-396.
28. Tractenberg R. E. Weiner M. F. Cummings J. L. Patterson M. B. and Thal L. J. (2005). Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach. The Journal of Neuropsychiatry and Clinical Neurosciences 17 51-60.
29. Välimäki T. H. Vehviläinen-Julkunen K. M. Pietilä A. M. and Pirttilä T. A. (2009). Caregiver depression is associated with a low sense of coherence and health-related quality of life. Aging and Mental Health 13 799-807.
30. Welsh K. A. et al. (1994). The consortium to establish a registry for Alzheimer's disease (CERAD). Part V. A normative study o. The neuropsychological battery. Neurology 44 609-614.